AnatomyOrganismsDiseasesChemicals and DrugsAnalytical, Diagnostic and Therapeutic Techniques and EquipmentPhenomena and ProcessesAnthropology, Education, Sociology and Social PhenomenaInformation ScienceHealth Care
Cardiomyopathy, DilatedCardiomyopathy, HypertrophicCardiomyopathiesCardiomyopathy, RestrictiveTakotsubo CardiomyopathyCardiomyopathy, Hypertrophic, FamilialChagas CardiomyopathyMyocardiumCardiomyopathy, AlcoholicEchocardiographyArrhythmogenic Right Ventricular DysplasiaDiabetic CardiomyopathiesElectrocardiographyVentricular Function, LeftMyocarditisVentricular Dysfunction, LeftHeart VentriclesHeart SeptumHeart FailureVentricular Outflow ObstructionMyocardial ContractionMyocytes, CardiacHeartStroke VolumeDeath, Sudden, CardiacCardiac MyosinsPeripartum PeriodEchocardiography, DopplerVentricular MyosinsFibrosisTachycardia, VentricularSarcomeresEndomyocardial FibrosisPedigreeMyocardial IschemiaMyosin Heavy ChainsHypertrophy, Left VentricularArrhythmias, CardiacEndocardiumPlakophilinsHeart TransplantationMutationLamin Type AVentricular RemodelingTroponin THemodynamicsCardiac Pacing, ArtificialDiastoleHeart DiseasesPuerperal DisordersSarcoglycansCardiomegalyDefibrillators, ImplantableDeath, SuddenMagnetic Resonance Imaging, CineDesmoglein 2Follow-Up StudiesSystoleMice, TransgenicDisease Models, AnimalCardiac CatheterizationGlycogen Storage Disease Type IIbPhenotypeMutation, MissenseIsolated Noncompaction of the Ventricular MyocardiumPregnancy Complications, CardiovascularDesminDystrophinTreatment OutcomeVentricular DysfunctionAdrenergic beta-AntagonistsMitral ValveHeart Function TestsMitral Valve InsufficiencyAblation Techniques3-IodobenzylguanidinePrognosisCardiotonic AgentsCatheter AblationTime FactorsHeart BlockPredictive Value of TestsBiopsyMuscular Dystrophy, DuchenneSyncopeEpicardial MappingTropomyosinElectrocardiography, AmbulatoryProspective StudiesVentricular Dysfunction, RightConnectinMyofibrilsMitochondria, HeartBundle-Branch BlockElectrophysiologic Techniques, CardiacTroponin IMyosinsEchocardiography, Doppler, ColorTachycardiaCoxsackievirus Infections
Risk for developing hypertrophic carDiagnosisHOCMObstructive and nonobstructive hypertrophic cardiomyopathyFeatures of hypertrophic cardiomyopathyNonobstructiveIdiopathic hypertroCardiacAmerican College ofMavacamtenMyocardialPatients2023Left ventricleVentricularRestrictive cardiomyopathyTherapiesEchocardiographyEpidemiologyOccursEtiologyDisease overviewAbnormalBristol MyersCenter of ExcellenceOutflowSudden deathThickenOverviewSarcomericSyncopePathwaysTreatmentsDisorderMutationsTherapeuticRarelyAlgorithmAblationSegmentCardiovascularPeopleGuidelineHeart muscleStiff
Risk for developing hypertrophic car1
  • Cats that are at risk for developing hypertrophic cardiomyopathy should be examined at least once a year by a veterinarian, preferably a cardiologist as HCM requires an echocardiogram (heart ultrasound) for definitive diagnosis and to understand the severity of the condition for the individual cat. (wisdompanel.com)
Diagnosis4
  • The BMS Quality Improvement Initiative in Hypertrophic Cardiomyopathy (QIIC) aims to support institutions and healthcare professionals involved in the diagnosis and care of patients with obstructive hypertrophic cardiomyopathy (oHCM) to improve the care gaps in making center-specific changes. (bms.com)
  • In a series of specially commissioned papers, clinicians, whose careers span the half a century since Teare's publication, review the pathogenesis, diagnosis and treatment of hypertrophic cardiomyopathy. (bmj.com)
  • Diagnosis of hypertrophic cardiomyopathy is determined by physical exam (a murmur), ECG abnormalities, and by ultrasound of the heart, which is called an echocardiogram. (gwinnettcitizen.com)
  • Diagnosis and Evaluation of Hypertrophic Cardiomyopathy: JACC State-of-the-Art Review. (msdmanuals.com)
HOCM4
  • Hypertrophic cardiomyopathy (HCM, or HOCM when obstructive) is a condition in which muscle tissues of the heart become thickened without an obvious cause. (wikipedia.org)
  • There are two types of HCM including Obstructive, which is the most common type, hypertrophic obstructive cardiomyopathy (HOCM) means the wall (septum) between the left ventricle and right ventricle thickens. (researchandmarkets.com)
  • Hypothesis/Objective: Observational study to characterize cardiovascular morbidity and survival in cats with preclinical nonobstructive (HCM) and obstructive (HOCM) hypertrophic cardiomyopathy and in apparently healthy cats (AH). (uni-muenchen.de)
  • This is called obstructive hypertrophic cardiomyopathy (HOCM). (cedars-sinai.org)
Obstructive and nonobstructive hypertrophic cardiomyopathy1
  • Learn more about the differences between obstructive and nonobstructive hypertrophic cardiomyopathy so you are better able to discuss its impact with your patients. (heart.org)
Features of hypertrophic cardiomyopathy2
  • Data link abnormal myocardial calcium kinetics to the cause of the inappropriate myocardial hypertrophy and specific features of hypertrophic cardiomyopathy (HCM), particularly in patients with diastolic functional abnormalities. (medscape.com)
  • The FF's autopsy showed an enlarged heart with left ventricular hypertrophy, but no "characteristic gross or histologic features of hypertrophic cardiomyopathy. (cdc.gov)
Nonobstructive3
  • Hypertrophic cardiomyopathy is described as either obstructive or nonobstructive. (kaiserpermanente.org)
  • Nonobstructive hypertrophic cardiomyopathy. (kaiserpermanente.org)
  • Sometimes HCM occurs without significant blocking of blood flow (nonobstructive hypertrophic cardiomyopathy). (heart.org)
Idiopathic hypertro2
  • Although HCM was written about and known as idiopathic hypertrophic subaortic stenosis (IHSS) or asymmetrical septal hypertrophy (ASH) decades ago, these terms were replaced by hypertrophic cardiomyopathy because the segmental hypertrophy can occur in any segment of the ventricle, not just the septum. (medscape.com)
  • Hypertrophic cardiomyopathy (HCM) is a well-recognized cardiac muscle disorder that has been known by various names, including idiopathic hypertrophic subaortic stenosis (IHSS). (medscape.com)
Cardiac11
  • Hypertrophic Cardiomyopathy (HCM) is the most common cardiac disease in cats worldwide. (wisdompanel.com)
  • To compare right ventricular thickness (RVT) and deformation of cardiac amyloidosis (CA) and hypertrophic cardiomyopathy (HCM) patients. (hindawi.com)
  • People with the inherited heart condition hypertrophic cardiomyopathy (HCM) who exercised vigorously did not have an increased incidence of serious cardiac events during three years of follow-up compared with people who exercised moderately or were inactive, according to a study being presented at the American College of Cardiology's Annual Scientific Session Together With the World Congress of Cardiology. (acc.org)
  • Syncopal events in patients with hypertrophic cardiomyopathy (HCM) are of concern as they are a vital consideration in algorithms for risk stratification for sudden cardiac death (SCD) and ICD implantation. (lu.se)
  • Cardiac magnetic resonance (CMR) with late gadolinium enhancement (LGE) revealed a substantial variation in the extent of myocardial scarring, a pathological hallmark of hypertrophic cardiomyopathy (HCM). (go.jp)
  • He also discusses the risk stratification criteria to identify patients at high risk for sudden cardiac death, as well as the updated guideline recommendations for sports participation in the setting of hypertrophic cardiomyopathy. (upmcphysicianresources.com)
  • Hypertrophic cardiomyopathy (HCM) is a common inherited heart disease with serious adverse outcomes, including heart failure, arrhythmias, and sudden cardiac death. (rupress.org)
  • Regression of dilated-hypokinetic hypertrophic cardiomyopathy by biventricular cardiac pacing. (ox.ac.uk)
  • The evolution of hypertrophic cardiomyopathy (HCM) towards dilatation and hypokinesis is an increasingly recognized complication with a high incidence of adverse outcomes, including sudden cardiac death, requiring defibrillator implantation and cardiac transplantation. (ox.ac.uk)
  • Snellville - Hypertrophic cardiomyopathy is the most common inherited cardiac disease and is present in 1 in 500 in the population. (gwinnettcitizen.com)
  • Thanks to technologic advances in cardiac imaging, multimodality studies provide insight into the pathophysiology of both ischemic and nonischemic cardiomyopathy. (medscape.com)
American College of1
  • Pharmaceutical agents took center stage in Washington on the first full day of the 2022 scientific sessions of the American College of Cardiology, such as an April 2 presentation on the use of the mavacamten for obstructive hypertrophic cardiomyopathy (OHC). (bioworld.com)
Mavacamten1
  • Key Pipeline therapies in the Hypertrophic Cardiomyopathy market are Mavacamten , CK-274, CT-G20, LCZ-696, PL-5028 , MYK-224, and several others are anticipated to enter the HCM market in the next decade. (ipsnews.net)
Myocardial9
  • Hypertrophic cardiomyopathy (HCM) is a primary myocardial disorder with an autosomal dominant pattern of inheritance that is characterized by hypertrophy of the left ventricles with histological features of myocyte hypertrophy, myfibrillar disarray, and interstitial fibrosis. (genome.jp)
  • The presence of angina pectoris and myocardial scarring in patients with hypertrophic cardiomyopathy (HCM) suggests that myocardial ischemia is a factor in the pathophysiology of the disease. (nih.gov)
  • Due to the ventricular hypertrophy caused by amyloid deposition, CA has often been misdiagnosed as hypertrophic cardiomyopathy (HCM), which has main macroscopic characteristics of myocardial wall thickening and myocyte hypertrophy [ 2 , 3 ]. (hindawi.com)
  • Study IV suggests adverse changes of circulating biomarkers reflecting myocardial matrix remodeling, microfibrosis and vascular endotheliopathy in the early stage of hypertrophic cardiomyopathy in the young. (dissertations.se)
  • Cardiovascular Magnetic Resonance Imaging of Myocardial Interstitial Expansion in Hypertrophic Cardiomyopathy. (upmcphysicianresources.com)
  • The hallmark of HCM is myocardial hypertrophy that is inappropriate and often asymmetric and that occurs in the absence of an obvious inciting hypertrophic stimulus. (medscape.com)
  • Myocardial strain imaging, a reproducible measure of LV systolic function, can identify subclinical LV dysfunction and patterns that suggest specific cardiomyopathies (eg, ischemic cardiomyopathy, amyloidosis, hypertrophic cardiomyopathy, chemotherapy-induced cardiotoxicity). (medscape.com)
  • The principal utility of CMR and its advantage over echocardiography for cardiomyopathy is its use of late gadolinium enhancement (LGE) , which visualizes myocardial tissue and detects scar, fibrosis, or infiltration. (medscape.com)
  • Further, T2* mapping, another parametric imaging approach, can detect and quantify myocardial iron deposition, primarily to assess iron overload cardiomyopathy. (medscape.com)
Patients6
  • Lahey Hospital & Medical Center is proud to launch the Hypertrophic Cardiomyopathy (HCM) Center, offering highly personalized care and leading-edge treatments to achieve a good quality of life and longevity for our patients with HCM. (4hcm.org)
  • The Hypertrophic Cardiomyopathy Center is accepting patients. (4hcm.org)
  • Last week, the FDA authorized marketing for Viz.AI's Viz HCM, a standalone ECG analysis software to identify adult patients for further follow-up for hypertrophic cardiomyopathy. (consultantlive.com)
  • The US Food and Drug Administration (FDA) has authorized marketing for Viz.Ai's Viz HCM, a standalone electrocardiogram (ECG) artificial intelligence algorithm used to identify and triage patients for further evaluation for the detection of hypertrophic cardiomyopathy (HCM) . (consultantlive.com)
  • Over the last 25 years, patients with hypertrophic cardiomyopathy (HCM) have been studied with a variety of methods employing physiological exercise that have made major contributions to disease management and are performed without increased risk. (unifi.it)
  • In patients with ischemic cardiomyopathy, TTE may show segmental areas of systolic dysfunction that are typically localized to a coronary distribution. (medscape.com)
20232
  • This "Hypertrophic Cardiomyopathy- Pipeline Insight, 2023" report provides comprehensive insights about 10+ companies and 10+ pipeline drugs in Hypertrophic Cardiomyopathy pipeline landscape. (researchandmarkets.com)
  • Hypertrophic Cardiomyopathy- Pipeline Insight, 2023" report outlays comprehensive insights of present scenario and growth prospects across the indication. (researchandmarkets.com)
Left ventricle1
Ventricular7
  • Beta blockers are used in both cases, but treatment with diuretics, a mainstay of CHF treatment, will exacerbate symptoms in hypertrophic obstructive cardiomyopathy by decreasing ventricular preload volume and thereby increasing outflow resistance (less blood to push aside the thickened obstructing tissue). (wikipedia.org)
  • Compared with sarcomeric hypertrophic cardiomyopathy, hypertrophic cardiomyopathy in RASopathies (R-HCM) is associated with higher prevalence of congestive heart failure and shows increased prevalence and severity of left ventricular outflow tract obstruction. (nih.gov)
  • Dilated cardiomyopathy: Enlargement of the left ventricular lumen, with thin walls showing reduced motion. (vin.com)
  • Hypertrophic cardiomyopathy is a congenital or acquired disorder characterized by marked ventricular hypertrophy with diastolic dysfunction (eg, due to valvular aortic stenosis, coarctation of the aorta, systemic hypertension). (msdmanuals.com)
  • The definition and classification of hypertrophic cardiomyopathy (HCM) have varied over the decades, primarily because the phenotypic expression of ventricular hypertrophy can result from a myriad of diseases, especially among children. (medscape.com)
  • Although the ventricle becomes hypertrophic, the ventricular cavity itself does not dilate, remaining normal or even small in size. (medscape.com)
  • Transthoracic echocardiography , the most widely available initial standard of care test for ventricular dysfunction, can help differentiate ischemic and nonischemic etiologies of cardiomyopathies. (medscape.com)
Restrictive cardiomyopathy1
  • Most cats with restrictive cardiomyopathy (RCM) are brought to veterinary attention due to dyspnea (83% in one study). (vin.com)
Therapies5
  • The companies and academics are working to assess challenges and seek opportunities that could influence Hypertrophic Cardiomyopathy R&D. The therapies under development are focused on novel approaches to treat/improve hypertrophic cardiomyopathy. (researchandmarkets.com)
  • Using the newest therapies, we can treat everyone with hypertrophic cardiomyopathy, no matter their health needs. (barnesjewish.org)
  • The Hypertrophic Cardiomyopathy Market is expected to boost in the next decade owing to increasing prevalence, influx of key pharma companies, launch of pipeline therapies and extensive R&D. (ipsnews.net)
  • The Hypertrophic Cardiomyopathy market report provides current treatment practices, emergi ng drugs, HCM market share of the individual therapies, current and forecasted Hypertrophic Cardiomyopathy market Size from 2018 to 2030 segmented by seven major markets. (ipsnews.net)
  • The Hypertrophic Cardiomyopathy Market is expected to witness the launch of upcoming therapies by key pharmaceutical companies including MyoKardia, Cytokinetics, Novartis, Celltrion, and several others. (ipsnews.net)
Echocardiography1
Epidemiology1
  • DelveInsight's " Hypertrophic Cardiomyopathy (HCM) Market Insights, Epidemiology, and Market Forecast-2030″ report delivers an in-depth understanding of Hypertrophic Cardiomyopathy, historical and forecasted epidemiology as well as the Hypertrophic Cardiomyopathy market trends in the 7MM ( the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan). (ipsnews.net)
Occurs1
  • Hypertrophic cardiomyopathy occurs because of a thickening of the heart muscle which shrinks the blood's path through the heart, forcing the heart to work harder while pumping blood. (umms.org)
Etiology1
  • The pattern of LGE can provide clues about the etiology of cardiomyopathy. (medscape.com)
Disease overview1
  • A detailed picture of the Hypertrophic Cardiomyopathy pipeline landscape is provided which includes the disease overview and Hypertrophic Cardiomyopathy treatment guidelines. (researchandmarkets.com)
Abnormal2
  • Hypertrophic cardiomyopathy is most often caused by abnormal genes in the heart muscle. (goredforwomen.org)
  • The myocardium is abnormal with cellular and myofibrillar disarray, although this finding is not specific for hypertrophic cardiomyopathy. (msdmanuals.com)
Bristol Myers2
  • Key companies proactively working in the Hypertrophic Cardiomyopathy market include MyoKardia (now acquired by Bristol Myers Squibb), Cytokinetics, Novartis, Celltrion, Palatin Technologies , among others. (ipsnews.net)
  • Viz.ai announces agreement with Bristol Myers Squibb to enable earlier detection and management of suspected hypertrophic cardiomyopathy (HCM). (consultantlive.com)
Center of Excellence3
  • At the Hypertrophic Cardiomyopathy Center of Excellence at the Washington University and Barnes-Jewish Heart & Vascular Center, we offer comprehensive care. (barnesjewish.org)
  • The Hypertrophic Cardiomyopathy Association has named us as one of only about 40 centers of excellence nationwide, and we are the only HCM center of excellence in the region. (barnesjewish.org)
  • The Hypertrophic Cardiomyopathy Program at the University of Maryland Heart & Vascular Center was recognized as the Center of Excellence by the Hypertrophic Cardiomyopathy Association (HCMA) - one of about 40 Centers of Excellence nationwide and the only HCMA-recognized center in Maryland. (umms.org)
Outflow1
  • Since the initial descriptions of hypertrophic cardiomyopathy (HCM), the feature that has attracted the greatest attention is the dynamic pressure gradient across the LV outflow tract. (medscape.com)
Sudden death1
  • People with hypertrophic cardiomyopathy are at higher risk for sudden death than people without the condition. (medlineplus.gov)
Thicken2
  • Hypertrophic cardiomyopathy is a genetic disease in which the heart muscle grows abnormally, making the heart muscle thicken. (kaiserpermanente.org)
  • Hypertrophic cardiomyopathy includes a group of heart disorders in which the walls of the ventricles (the two lower chambers of the heart) thicken (hypertrophy) and become stiff. (msdmanuals.com)
Overview1
  • Overview of Cardiomyopathy Cardiomyopathy refers to progressive impairment of the structure and function of the muscular walls of the heart chambers. (msdmanuals.com)
Sarcomeric1
  • Hypertrophic cardiomyopathy (HCM) is predominantly caused by mutations in genes encoding sarcomeric proteins. (eur.nl)
Syncope1
  • In a university-based referral center setting, the presenting concern in cats that are subsequently found to have hypertrophic cardiomyopathy (HCM) is 33%, 46%, 17%, and 4% in cats with an incidentally detected heart murmur, signs of congestive heart failure, signs of aortic thromboembolism, and syncope, respectively. (vin.com)
Pathways1
  • Stress activated signalling impaired protein quality control pathways in human hypertrophic cardiomyopathy. (bvsalud.org)
Treatments1
  • If you would like more information on hypertrophic cardiomyopathy, other cardiovascular conditions or treatments, you can count on Dr. Marc Unterman and the experienced physicians at Eastside Heart and Vascular for all of your heart care needs. (gwinnettcitizen.com)
Disorder4
  • Hypertrophic Cardiomyopathy (HCM) is a genetic disorder caused by the caused by a change or mutation in one or more genes and is mostly passed on through families. (researchandmarkets.com)
  • Hypertrophic Cardiomyopathy (Discovered in the Maine Coon) is a disorder where the heart muscle wall increases in thickness, eventually leading to heart failure. (wisdompanel.com)
  • Background: Hypertrophic cardiomyopathy is the most prevalent heart disorder in cats and principal cause of cardiovascular morbidity and mortality. (uni-muenchen.de)
  • The term cardiomyopathy is used only when a disorder directly affects the heart muscle. (msdmanuals.com)
Mutations2
  • Familial hypertrophic cardiomyopathy is inherited as an autosomal dominant trait and is attributed to mutations in one of a number of genes that encode for the sarcomere proteins. (wikipedia.org)
  • Hypertrophic cardiomyopathy is caused by one or more gene mutations within the proteins of heart muscle cells. (news-medical.net)
Therapeutic1
  • A high quantitative (central lab submission) NT-proBNP result does not differentiate between cardiomyopathy types (a differentiation that is of unproven therapeutic importance in cats anyway), but a low or normal value is strongly suggestive of the absence of cardiomyopathy. (vin.com)
Rarely1
Algorithm1
  • The Report also offers current Hypertrophic Cardiomyopathy therapy practice/algorithm, market drivers, market barriers and unmet medical needs to curate best of the opportunities and assesses the underlying potential of the market. (ipsnews.net)
Ablation1
Segment2
  • This segment of the Hypertrophic Cardiomyopathy report encloses its detailed analysis of various drugs in different stages of clinical development, including phase III, II, I, preclinical and Discovery. (researchandmarkets.com)
  • Finally, several electrocardiographic abnormalities have been assessed as possible markers for feline hypertrophic cardiomyopathy: ST segment changes, increased QRS width, and increased QT interval prolongation have all been associated with cardiomyopathy in small case series of cats. (vin.com)
Cardiovascular1
  • Hypertrophic cardiomyopathy (HCM) is the most common genetic cardiovascular disease. (medscape.com)
People10
  • Younger people are likely to have a more severe form of hypertrophic cardiomyopathy. (medlineplus.gov)
  • Close family members of people who have been diagnosed with hypertrophic cardiomyopathy may be screened for the condition. (medlineplus.gov)
  • Some people with hypertrophic cardiomyopathy may not have symptoms and will have normal lifespan. (medlineplus.gov)
  • Hypertrophic cardiomyopathy can affect people at any age and is equally common among men and women. (news-medical.net)
  • Few people with hypertrophic cardiomyopathy develop symptoms and many find that their quality of life is not compromised. (news-medical.net)
  • This complication affects only a small proportion of people with hypertrophic cardiomyopathy. (news-medical.net)
  • Some people with hypertrophic cardiomyopathy don't have symptoms while others may only feel symptoms with exercise or exertion. (goredforwomen.org)
  • People who exercise often and hard may have changes in their heart muscle that can be confused with hypertrophic cardiomyopathy. (peacehealth.org)
  • Many people with Hypertrophic Cardiomyopathy go undiagnosed because they have few, if any, symptoms and can live regular lives with no noticeable problems. (ipsnews.net)
  • Most people with HCM have a form of the disease in which the wall that separates the two bottom chambers of the heart becomes enlarged and restricts blood flow out of the heart (obstructive hypertrophic cardiomyopathy). (heart.org)
Guideline2
  • The CDC Tier-Classified Guideline Database includes three Tier 1 guidelines on hypertrophic cardiomyopathy (HCM). (cdc.gov)
  • Follow updated guideline recommendations for sports participation in the setting of hypertrophic cardiomyopathy including the concept of shared decision. (upmcphysicianresources.com)
Heart muscle5
  • Hypertrophic cardiomyopathy (HCM) is a condition in which the heart muscle becomes thick. (medlineplus.gov)
  • It is a heart muscle disease in which the muscle is thickened (hypertrophic). (researchandmarkets.com)
  • Hypertrophic cardiomyopathy (say "hy-per-TROH-fik kar-dee-oh-my-AWP-uh-thee") happens when the heart muscle grows too thick. (peacehealth.org)
  • Hypertrophic Cardiomyopathy is a condition in which the heart muscle thickens abnormally (hypertrophied). (ipsnews.net)
  • Dilated Cardiomyopathy Dilated cardiomyopathy is a group of heart muscle disorders in which the ventricles (the two lower chambers of the heart) enlarge (dilate) but are not able to pump enough blood for the body's. (msdmanuals.com)
Stiff1
  • Hypertrophic cardiomyopathy is a hereditary condition where the heart fails to pump properly because the heart muscles (myocardium) have thickened (hypertrophied) and become stiff. (news-medical.net)